Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients
about
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell TransplantationDonor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell TransplantationDesensitization for solid organ and hematopoietic stem cell transplantationAlloprimed CD8(+) T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms.Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production.A critical role for the TLR4/TRIF pathway in allogeneic hematopoietic cell rejection by innate immune cells.Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cellsCritical role of sensitized serum in rejection of allogeneic bone marrow cells.Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model.High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell TransplantationCostimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitizationSyngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunityDonor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.Composite tissue transplantation: a rapidly advancing fieldStrategic nonmyeloablative conditioning: CD154:CD40 costimulatory blockade at primary bone marrow transplantation promotes engraftment for secondary bone marrow transplantation after engraftment failure.The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA?On the role of HLA antibodies in hematopoietic stem cell transplantation.The need for inducing tolerance in vascularized composite allotransplantation.Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation.Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection.Strategies to inhibit alloantibody production in alloprimed murine recipients of hematopoietic stem cell grafts.B-cell-dependent memory T cells impede nonmyeloablative mixed chimerism induction in presensitized mice.B cells versus T cells as primary barrier to hematopoietic engraftment in allosensitized recipients.Expansion of donor-reactive host T cells in primary graft failure after allogeneic hematopoietic SCT following reduced-intensity conditioning.Panel reactive antibody in thalassemic serum inhibits proliferation and differentiation of cord blood CD34+ cells in vitro.The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.Successful transplantation of kidney allografts in sensitized rats after syngeneic hematopoietic stem cell transplantation and fludarabine.Application of mesenchymal stromal cells in bone marrow transplantation for sensitized recipients.
P2860
Q26738469-3BC4CBB8-B980-4A13-9AFF-7F50D1ED2CDBQ26767440-4DEE7685-C9E7-4963-92AB-918F154CB211Q26863564-8833EAE8-0C44-4E00-ABEC-1005DE0D0193Q33601185-11847F9F-C294-4BF8-9CF2-C8BA5B6C0F69Q33856960-4D85E132-B826-44C1-89C6-C68926826293Q34443169-C8075576-E7B3-4782-9063-A4C76D224693Q34475141-F063D936-BB50-4F83-BAA9-248AE1A75A74Q34498297-87D5234F-F411-43DB-8ECB-0AA3959D8C73Q34868407-F8802942-86C0-4703-981A-66FF47E1F221Q34976550-E3186B77-9231-4DF0-BBB4-22EC377BD43EQ35073502-0E7402DE-B11B-470B-9F45-C6888D51F0B6Q35372567-4960668B-1F01-4FA4-AF4B-17969B2B5963Q35864018-5ABD4E75-204C-4AAD-B222-3841320E6560Q36491890-49139241-606E-4450-B605-95ED0FEC0724Q36915859-F417A956-A812-4DF3-B70D-B100FA1F92D9Q37142892-4C48CC03-51DD-433B-8615-0968FFCBB786Q37203057-5161CD61-1452-47D2-A2B0-8362A07253F0Q37400003-38CF12FC-5072-4831-9D40-C24E2372A539Q37974520-CFB5FE19-374D-4D99-BC2D-4C8BCF25B289Q38065269-1F38E9B9-BE59-4CD4-9D06-D9876922AAF6Q38068404-E6003970-18E2-4A21-A9A9-429F3D288C4BQ38155240-961871C9-5708-4F4F-9AD5-37A3B2E3BBFEQ40883726-9A5E027B-1F11-4E19-99AB-1BD0FC939138Q41242229-F92EAB4A-7923-4A1A-A901-AB8033CA0EBBQ42016816-4AA05250-A8A5-4DCD-AA61-28C1BAFBA81DQ43188515-D7C417F9-7381-4730-9BF7-F0AC838C8B9DQ45890363-4686C4EE-1677-40D2-9E0B-5A75FEC53337Q45938991-B7E37013-3643-4FBA-A4E4-80C03C4F0E5EQ50042370-62D5869A-2356-4488-AE4C-168F7E23EDFCQ50450890-F1050496-5A6C-49A9-B962-7A0AC4AFDD31Q50505919-863EB191-CAFC-489A-9F96-0FCE11E7B558
P2860
Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Humoral immunity is the domina ...... tment in sensitized recipients
@ast
Humoral immunity is the domina ...... tment in sensitized recipients
@en
type
label
Humoral immunity is the domina ...... tment in sensitized recipients
@ast
Humoral immunity is the domina ...... tment in sensitized recipients
@en
prefLabel
Humoral immunity is the domina ...... tment in sensitized recipients
@ast
Humoral immunity is the domina ...... tment in sensitized recipients
@en
P2093
P2860
P1433
P1476
Humoral immunity is the domina ...... tment in sensitized recipients
@en
P2093
Carrie L Schanie
Mariano Dy-Liacco
Michael K Tanner
Paula M Chilton
Suzanne T Ildstad
Yiming Huang
P2860
P304
P356
10.1182/BLOOD-2006-04-017467
P407
P577
2006-08-03T00:00:00Z